CBAT Strangle Strategy

CBAT (CBAK Energy Technology, Inc.), in the Industrials sector, (Electrical Equipment & Parts industry), listed on NASDAQ.

CBAK Energy Technology, Inc., together with its subsidiaries, develops, manufactures, and sells lithium batteries in Mainland China, the United States, Korea, Europe, and internationally. Its products are used in various applications, including electric vehicles, such as electric cars, electric buses, and hybrid electric cars and buses; light electric vehicles that include electric bicycles, electric motors, and sight-seeing cars; and electric tools, energy storage, uninterruptible power supply, and other high power applications, as well as cordless power tools. The company was formerly known as China BAK Battery, Inc. and changed its name to CBAK Energy Technology, Inc. in January 2017. CBAK Energy Technology, Inc. was incorporated in 1999 and is based in Dalian, China.

CBAT (CBAK Energy Technology, Inc.) trades in the Industrials sector, specifically Electrical Equipment & Parts, with a market capitalization of approximately $70.3M, a beta of 1.30 versus the broader market, a 52-week range of 0.77-1.25, average daily share volume of 135K, a public-listing history dating back to 2005, approximately 1K full-time employees. These structural characteristics shape how CBAT stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.30 indicates CBAT has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a strangle on CBAT?

A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.

Current CBAT snapshot

As of May 15, 2026, spot at $0.79, ATM IV 23.70%, IV rank 1.30%, expected move 6.79%. The strangle on CBAT below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.

Why this strangle structure on CBAT specifically: CBAT IV at 23.70% is on the cheap side of its 1-year range, which favors premium-buying structures like a CBAT strangle, with a market-implied 1-standard-deviation move of approximately 6.79% (roughly $0.05 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CBAT expiries trade a higher absolute premium for lower per-day decay. Position sizing on CBAT should anchor to the underlying notional of $0.79 per share and to the trader's directional view on CBAT stock.

CBAT strangle setup

The CBAT strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CBAT near $0.79, the first option leg uses a $0.83 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CBAT chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CBAT shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$0.83	N/A
Buy 1	Put	$0.75	N/A

CBAT strangle risk and reward

Net Premium / Debit: N/A
Max Profit (per contract): Unbounded
Max Loss (per contract): Unbounded
Breakeven(s): None on modeled curve
Risk / Reward Ratio: N/A

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.

CBAT strangle payoff curve

Modeled P&L at expiration across a range of underlying prices for the strangle on CBAT. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use strangle on CBAT

Strangles on CBAT are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the CBAT chain.

CBAT thesis for this strangle

The market-implied 1-standard-deviation range for CBAT extends from approximately $0.74 on the downside to $0.84 on the upside. A CBAT long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current CBAT IV rank near 1.30% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on CBAT at 23.70%. As a Industrials name, CBAT options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CBAT-specific events.

CBAT strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CBAT positions also carry Industrials sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CBAT alongside the broader basket even when CBAT-specific fundamentals are unchanged. Always rebuild the position from current CBAT chain quotes before placing a trade.

Frequently asked questions

What is a strangle on CBAT?: A strangle on CBAT is the strangle strategy applied to CBAT (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With CBAT stock trading near $0.79, the strikes shown on this page are snapped to the nearest listed CBAT chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are CBAT strangle max profit and max loss calculated?: Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the CBAT strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 23.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a CBAT strangle?: The breakeven for the CBAT strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current CBAT market-implied 1-standard-deviation expected move is approximately 6.79%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a strangle on CBAT?: Strangles on CBAT are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the CBAT chain.
How does current CBAT implied volatility affect this strangle?: CBAT ATM IV is at 23.70% with IV rank near 1.30%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.